BackRani Therapeutics Holdings Overview

Rani Therapeutics Holdings Other Current Assets

Rani Therapeutics Holdings's other current assets is $1.1M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1.09M
29.92% YoYΔ $251000.00 vs prior year quarter

Peer average / median

Loading

Rani Therapeutics Holdings Other Current Assets History

Loading

Rani Therapeutics Holdings vs. peers: Other Current Assets Comparison

Loading

Rani Therapeutics Holdings Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rani Therapeutics Holdings (RANI) FAQ

The latest other current assets for RANI is $1.1M as of June 2026. That compares with $840K in the prior-year period — up 29.9% year over year. Investors often review this figure alongside Rani Therapeutics Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, RANI's other current assets moved from $840K to $1.1M — a 29.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Rani Therapeutics Holdings's operating scale or balance-sheet position.

A other current assets figure of $1.1M for RANI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RANI's other current assets ($1.1M), review year-over-year change from $840K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Rani Therapeutics Holdings's other current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.